Immunoregulatory effects of very low density lipoprotein from healthy individuals and metabolic syndrome patients on glial cells
- 1 September 2019
- journal article
- research article
- Published by Elsevier in Immunobiology
- Vol. 224 (5) , 632-637
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology, Taiwan
This publication has 26 references indexed in Scilit:
- Effects of Electronegative VLDL on Endothelium Damage in Metabolic SyndromeDiabetes Care, 2012
- Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseasesBrain Research Bulletin, 2012
- Lipotoxicity and Impaired High Density Lipoprotein-Mediated Reverse Cholesterol Transport in Chronic Kidney DiseaseJournal of Renal Nutrition, 2010
- The vascular contribution to Alzheimer's diseaseClinical Science, 2010
- Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular eventsJournal Of Hypertension, 2010
- Lipoprotein Particle Size and Concentration by Nuclear Magnetic Resonance and Incident Type 2 Diabetes in WomenDiabetes, 2010
- Overproduction of Very Low–Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- The Pafah1b Complex Interacts with the Reelin Receptor VLDLRPLOS ONE, 2007
- Low-Density Lipoprotein in Hypercholesterolemic Human Plasma Induces Vascular Endothelial Cell Apoptosis by Inhibiting Fibroblast Growth Factor 2 TranscriptionCirculation, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001